LSP HEF 2
Investments range between EUR 10 million and EUR 30 million
LSP HEF 2 (Health Economic Fund) seeks to invest in health care technology companies in late-stage development or early-stage commercialization. Products or technologies need to have the potential to improve the quality of healthcare and lower the cost of care at the same time. LSP HEF 2’s geographical focus is primarily Europe and the US.
LSP Advisory B.V.
Johannes Vermeerplein 9
1071 DV Amsterdam, the Netherlands
Company Registration Number: 34296447
LSP Advisory B.V. is an alternative investment fund manager authorized and regulated in accordance with laws of the Netherlands.
Fast facts
-
StatusActive
-
Launch2018
-
SizeEUR 280 m
-
SFDR classificationArt. 8
Investment advisory committee
-
ChairpersonAndre Olijslager
-
Fundamental VR
- Sector Healthcare
- Country United Kingdom
- Entry 2022
- Exit
-
Xeltis
- Sector Healthcare
- Country Switzerland
- Entry 2014
- Exit
-
Perfuze
- Sector Healthcare
- Country Ireland
- Entry 2022
- Exit
-
Nobi
- Sector Healthcare
- Country Belgium
- Entry 2022
- Exit
-
DOTS Technology
- Sector Healthcare
- Country United States
- Entry 2021
- Exit
-
iStar Medical
- Sector Healthcare
- Country Belgium
- Entry 2019
- Exit
-
Neurent Medical
- Sector Healthcare
- Country Ireland
- Entry 2020
- Exit
-
One Projects
- Sector Healthcare
- Country Ireland/Germany
- Entry 2020
- Exit
-
Atlantic Therapeutics
- Sector Healthcare
- Country Ireland
- Entry 2018
- Exit
-
Lumeon
- Sector Healthcare
- Country United Kingdom
- Entry 2018
- Exit
-
Endotronix
- Sector Healthcare
- Country United States
- Entry 2018
- Exit
-
Vicentra
- Sector Healthcare
- Country Netherlands
- Entry 2016
- Exit